NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to advancing pharmaceutical science, and understanding the core functions of key compounds is essential. Today, we examine the detailed 7-ethyl-10-hydroxycamptothecin mechanism of action, a critical aspect of its therapeutic potential in oncology.

7-Ethylcamptothecin, also known as SN-38, functions as a potent topoisomerase I inhibitor. This enzyme is crucial for DNA replication and repair. By inhibiting topoisomerase I, 7-Ethylcamptothecin causes DNA strand breaks, ultimately leading to programmed cell death (apoptosis) in rapidly proliferating cancer cells. This targeted approach is what makes it such a promising agent in cancer therapy.

The efficacy of this mechanism has been extensively studied, with research focusing on its 7-Ethylcamptothecin synthesis and antitumor activity. Scientists often choose to buy 7-Ethylcamptothecin online to conduct these critical in vitro and in vivo experiments. The compound's ability to exert strong cytotoxic effects makes it a valuable tool for developing next-generation cancer drugs.

As the active metabolite of Irinotecan, understanding the 7-ethyl-10-hydroxycamptothecin mechanism of action provides direct insights into how Irinotecan works and how its efficacy can be enhanced. Challenges such as poor solubility and rapid inactivation have led to research into novel delivery systems, like liposomes, to improve its therapeutic index. NINGBO INNO PHARMCHEM CO.,LTD. supports these research efforts by providing high-quality 7-Ethylcamptothecin.